# Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective

> **NCT03602326** · NA · COMPLETED · sponsor: **Gokhan Yazici** · enrollment: 39 (actual)

## Conditions studied

- Stroke, Acute
- Ischemic Stroke

## Interventions

- **OTHER:** Neurodevelopmental Therapy-Bobath group
- **OTHER:** Standart Rehabilitation Group (SR group)

## Key facts

- **NCT ID:** NCT03602326
- **Lead sponsor:** Gokhan Yazici
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2018-07-06
- **Final completion:** 2018-07-13
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602326, "Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03602326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*